期刊
PEDIATRIC BLOOD & CANCER
卷 55, 期 3, 页码 464-470出版社
WILEY
DOI: 10.1002/pbc.22603
关键词
differentiation; gene expression; kinase inhibitors; neuroblastoma; retinoic acid
资金
- Medical Faculty of the Martin-Luther University of Halle-Wittenberg [FKZ 4/39]
- NBL3/Wilhelm-Roux-Programm [FKZ 4/39]
Background. Retinoids can induce differentiation of neuroblastoma (NB) cells and are in clinical use for the treatment of patients with NB. Despite improvements of standard treatment during the last years, many patients with NB still relapse and new treatment options for these patients are required. Procedure. We analyzed NB cells after incubation with retinoids by using Affymetrix HG_U133A microarrays, reverse transcription-polymerase chain reaction (RT-PCR), and flow cytometry. Sequencing of RT-PCR products was applied for determination of CD117 mRNA sequences from NB cell lines. In addition, we tested sensitivity of NB cells for the kinase inhibitor imatinib mesylate after treatment with retinoids. Results. Treatment of NB cells with retinoids induced expression of several genes including the retinoid metabolizing enzymes CYP26A1 and CYP26B1. In addition, we observed up-regulation of CD117 (KIT), particularly after long-term treatment with retinoids. Sequencing of CD117 mRNA from NB cell lines revealed heterozygosity for a non-synonymous single nucleotide polymorphism in SH-SY5Y NB cells. Up-regulation of CD117 in NB cells correlated with increased sensitivity for the kinase inhibitor imatinib mesylate. Conclusions. The combination of retinoids with kinase inhibitors might be worth exploring further for the treatment of NB patients. Pediatr Blood Cancer. 2010;55:464 470. (C) 2010 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据